´
W. Kosnik et al. / Tetrahedron: Asymmetry 16 (2005) 1975–1981
1980
J 2.5 Hz, H-1), 2.49 (m, 1H, RJ 27.0 Hz, H-2), 1.11
(d, 1H, J 6.7 Hz, CH3); b-D-gluco-, (4.5%) d 9.49 (s,
1H, OOH), 4.72 (d, 1H, J 7.8 Hz, H-1), 2.49 (m, 1H,
RJ 36.4 Hz, H-2), 1.11 (d, 1H, J 7.0 Hz, CH3); HR-
MS/ESI taken for the mixture 41 calcd for C28H32O6Na
(M+Na)+ 487.2091. Found: 487.2093.
4.15. 3,5-Di-O-benzyl-2-deoxy-b-D-erythropentofuranosyl
hydroperoxide 39
Yield 27%; [a]D À9.8 (c 0.60, CHCl3); IR (film): m 3369
(O–H), 2866, 1089, 698 cmÀ1 1H NMR (500 MHz,
;
CDCl3): d 9.16 (s, 1H, OOH), 5.61 (br d, 1H, J
5.8 Hz, H-1), 4.61–4.44 (m, 4H, 2 · Bn), 4.30 (m, 1H,
J 5.0, 6.7, 7.2 Hz, H-3), 4.20 (m, 1H, J 4.5, 4.2,
5.0 Hz, H-4), 3.71 (dd, 1H, J 10.3, 4.5 Hz, H-5a), 3.57
(dd, 1H, J 10.3, 4.2 Hz, H-5b), 2.37 (ddd, 1H, J 13.9,
1.3, 7.2 Hz, H-2a), 2.16 (dt, 1H, J 13.9, 5.8, 6.7 Hz, H-
2b); 13C NMR (125 MHz, CDCl3): d 107.44 (C-1),
83.16 (C-4), 78.32 (C-3), 73.46 (Bn), 72.04 (Bn), 70.24
(C-5), 36.70 (C-2); HR-MS/ESI calcd for C19H22O5Na
(M+Na)+ 353.1359. Found: 353.1348. Anal. Calcd for
C19H22O5: C, 69.07; H, 6.71. Found: C, 69.41; H, 6.86.
4.12. 2-Deoxy-3,5-di-O-acetyl-a-D-erythropentofuranosyl
hydroperoxide 35
Yield 34%; IR (film): m 3362 (O–H), 1741 (C@O),
1238 cmÀ1 1H NMR (500 MHz, CDCl3): d 8.88 (s,
.
1H, OOH), 5.67 (dd, 1H, J 6.5, 0.9 Hz, H-1), 5.03
(ddd, 1H, J 7.8, 2.7, 3.4 Hz, H-3), 4.37 (m, 1H, H-4),
4.33 (dd, 1H, J 11.8, 3.5 Hz, H-5a), 4.17 (dd, 1H, J
11.7, 4.6 Hz, H-5b), 2.49 (ddd, 1H, J 14.7, 6.5, 7.8 Hz,
H-2a), 2.09 (s, 3H, Ac), 2.08 (s, 3H, Ac) 1.99 (br d,
1H, J 15.0 Hz, H-2b); 13C NMR (125 MHz, CDCl3): d
170.71 (Ac), 170.60 (Ac), 107.67 (C-1), 81.38 (C-3),
73.34 (C-4), 63.62 (C-5), 35.95 (C-2), 20.88 (Ac), 20.74
(Ac); HR-MS/ESI calcd for C9H14O7Na (M+Na)+
257.0632. Found: 257.0624. Compound 35 did not give
consistent elemental analysis and since contaminations
were found in its NMR spectrum, [a]D was not
provided.
4.16. 2-Deoxy-3,5-di-O-pivaloyl-a-D-erythropentofurano-
syl hydroperoxide 37
Yield 44%; [a]D 95.4 (c 0.73, CHCl3); IR (film): m 3388
(O–H), 2973, 1730 (C@O), 1157 cmÀ1
;
1H NMR
(500 MHz, CDCl3): d 8.69 (s, 1H, OOH), 5.67 (dd,
1H, J 6.3, 1.3 Hz, H-1), 5.05 (ddd, 1H, J 7.7, 2.1,
3.3 Hz, H-3), 4.35 (q, 1H, J 3.6, 3.9, 3.3 Hz, H-4), 4.29
(dd, 1H, J 11.9, 3.6 Hz, H-5a), 4.19 (dd, 1H, J 11.9,
3.9 Hz, H-5b), 2.48 (ddd, 1H, J 15.3, 6.3, 7.7 Hz, H-
2a), 1.97 (dt, 1H, J 15.3, 1.3, 2.1 Hz, H-2b), 1.21 (s,
9H, Piv), 1.20 (s, 9H, Piv); 13C NMR (125 MHz,
CDCl3): d 178.24 (Piv), 178.00 (Piv), 107.82 (C-1),
81.99 (C-3), 73.40 (C-4), 63.62 (C-5), 38.81 (Piv), 38.56
(Piv), 36.18 (C-2), 27.17 (Piv), 26.93 (Piv); HR-MS/ESI
calcd for C15H26O7Na (M+Na)+ 341.1571. Found:
341.1575. Anal. Calcd for C15H26O7: C, 56.59; H, 8.23.
Found: C, 56.85; H, 8.32.
4.13. 2-Deoxy-3,5-di-O-acetyl-b-D-erythropentofuranosyl
hydroperoxide 38
Yield 21%; IR (film): m 3361 (O–H), 1739 (C@O) cmÀ1
;
1H NMR (500 MHz, CDCl3): d 10.05 (s, 1H, OOH),
5.63 (dd, 1H, J 1.7, 6.1 Hz, H-1), 5.09 (ddd, 1H,
J 7.9, 5.6, 3.2 Hz, H-3), 4.71 (dd, 1H, J 11.5, 8.7 Hz,
H-5a), 4.26–4.19 (m, 2H, H-4, H-5b), 2.41 (ddd, 1H, J
14.7, 1.7, 7.9 Hz, H-2a), 2.21 (dt, 1H, J 14.7, 6.1,
5.7 Hz, H-2b), 2.14 (s, 3H, Ac), 2.06 (s, 3H, Ac); 13C
NMR (125 MHz, CDCl3): d 172.55 (Ac), 170.72 (Ac),
108.04 (C-1), 83.96 (C-3), 74.08 (C-4), 65.44 (C-5),
35.88 (C-2), 21.19 (Ac), 20.80 (Ac); DEPT 135
(125 MHz, CDCl3): d 108.04 (C-1), 83.96 (C-3), 74.08
(C-4), 65.44 (C-5), 35.88 (C-2), 21.19 (Ac), 20.80 (Ac);
HR-MS/ESI calcd for C9H14O7Na (M+Na)+ 257.0632.
Found: 257.0639. Compound 38 did not give consistent
elemental analysis and since contaminations were found
in its NMR spectrum, [a]D was not provided.
4.17. 2-Deoxy-3,5-di-O-pivaloyl-b-D-erythropentofurano-
syl hydroperoxide 40
Yield 36%; [a]D = À97.0 (c 0.81, CHCl3); IR (film): m
1
3369 (O–H), 2973, 1731 (C@O), 1154 cmÀ1; H NMR
(500 MHz, CDCl3): d 10.32 (s, 1H, OOH), 5.63 (d, 1H,
J 1.2, 6.1 Hz, H-1), 5.05 (ddd, 1H, J 7.9, 5.8, 3.3 Hz,
H-3), 4.81 (dd, 1H, J 12.1, 9.9 Hz, H-5a), 4.20–4.15
(m, 2H, H-4, H-5b), 2.43 (ddd, 1H, J 14.6, 1.2, 7.9 Hz,
H-2a), 2.20 (dt, 1H, J 14.6, 6.1, 7.9 Hz, H-2b), 1.24 (s,
9H, Piv), 1.20 (s, 9H, Piv); 13C NMR (125 MHz,
CDCl3): d 180.35 (Piv), 178.49 (Piv), 108.07 (C-1),
84.36 (C-3), 73.94 (C-4), 65.62 (C-5), 39.19 (Piv), 38.57
(Piv), 35.95 (C-2), 27.13 (Piv), 27.01 (Piv); HR-MS/ESI
calcd for C15H26O7Na (M+Na)+ 341.1571. Found:
341.1581. Anal. Calcd for C15H26O7: C, 56.59; H, 8.23.
Found: C, 56.81; H, 8.02.
4.14. 3,5-Di-O-benzyl-2-deoxy-a-D-erythropentofuranosyl
hydroperoxide 36
Yield 42%; [a]D 66.2 (c 0.74, CHCl3); IR (film): m 3328
(O–H), 2863, 1095, 698 cmÀ1 1H NMR (500 MHz,
;
CDCl3): d 8.94 (s, 1H, OOH), 5.61 (dd, 1H, J 6.5,
2.1 Hz, H-1), 4.57–4.42 (m, 4H, 2 · Bn), 4.33 (m, 1H,
J 4.4, 3.8, 4.5 Hz, H-4), 4.01 (ddd, 1H, J 7.7, 3.2,
4.4 Hz, H-3), 3.58 (dd, 1H, J 10.6, 3.8 Hz, H-5a),
3.42 (dd, 1H, J 10.6, 4.5 Hz, H-5b), 2.32 (ddd, 1H, J
14.6, 6.5, 7.7 Hz, H-2a), 1.96 (ddd, 1H, J 14.6, 2.1,
4.18. Epoxidation of 43; general procedure18,20
Hydroperoxide 18, 29–31, 34, 36, 37, 39 or 40
(0.103 mM) in toluene (20 mL) was treated with DBU
(16 lL, 0.103 mM). After 10 min at room temperature
the mixture was treated with quinone 43 (molar equiva-
lents, see Table 1) in toluene (10 mL). The progress of
the reaction was monitored by TLC. After the disap-
pearance of quinone, the mixture was washed with
3.2 Hz, H-2b); 13C NMR (125 MHz, CDCl3):
d
107.77 (C-1), 82.85 (C-4), 78.16 (C-3), 73.56 (Bn),
71.67 (Bn), 69.94 (C-5), 35.68 (C-2); HR-MS/ESI calcd
for C19H22O5Na (M+Na)+ 353.1359. Found: 353.1365.
Anal. Calcd for C19H22O5: C, 69.07; H, 6.71. Found:
C, 69.15; H, 6.85.